Katsunari Yane

Department Of Otolaryngology Head And Neck Surgery, 1248-1 Otoda Cho
Ikoma, 6300293, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer.

A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer.

Journal: Japanese journal of clinical oncology
Published: October 11, 2025

Low Ki-67 labeling index is a clinically useful predictive factor for recurrence-free survival in patients with papillary thyroid carcinoma.

Low Ki-67 labeling index is a clinically useful predictive factor for recurrence-free survival in patients with papillary thyroid carcinoma.

Journal: Journal of pathology and translational medicine
Published: September 28, 2024

Epidemiological trends in head and neck cancer in Nara Prefecture, Japan, from 2000-2021: The impact of the COVID-19 pandemic.

Epidemiological trends in head and neck cancer in Nara Prefecture, Japan, from 2000-2021: The impact of the COVID-19 pandemic.

Journal: Auris, nasus, larynx
Published: July 26, 2024

Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE).

Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE).

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 01, 2022

Factors predictive of the development of hypothyroidism after intensity-modulated radiation therapy for pharyngeal cancer.

Factors predictive of the development of hypothyroidism after intensity-modulated radiation therapy for pharyngeal cancer.

Journal: Acta oto-laryngologica
Published: November 05, 2021

Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial.

Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial.

Journal: Medical oncology (Northwood, London, England)
Published: August 17, 2021

A study of 24 cases of salivary gland carcinoma with distant metastasis.

A study of 24 cases of salivary gland carcinoma with distant metastasis.

Journal: Molecular and clinical oncology
Published: March 05, 2021

Role of debulking surgery in combination with immune therapy: A successfully treated case of locally advanced mucosal melanoma.

Role of debulking surgery in combination with immune therapy: A successfully treated case of locally advanced mucosal melanoma.

Journal: Molecular and clinical oncology
Published: December 21, 2020

A study of 17 cases for the identification of prognostic factors for anaplastic thyroid carcinoma.

A study of 17 cases for the identification of prognostic factors for anaplastic thyroid carcinoma.

Journal: Molecular and clinical oncology
Published: May 01, 2020

Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.

Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.

Journal: Cancer
Published: February 10, 2020

Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma.

Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma.

Journal: Cancers
Published: January 28, 2020

Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel KIF5B-ALK Fusion Oncokinase.

Use of ALK Immunohistochemistry for Optimal Therapeutic Strategy of Pulmonary Large-cell Neuroendocrine Carcinoma and Identification of a Novel KIF5B-ALK Fusion Oncokinase.

Journal: Anticancer research
Published: November 04, 2018
Showing 1-12 of 23

Last Updated: 09/26/2026